EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endometrial Microbiome and Implantation: From Basic Knowledge to Clinical Medicine

Daiki Hiratsuka iD, Mitsunori Matsuo, Yasushi Hirota

Reproductive Medicine and Biology · 2026-01 · 25 (1)

DOI: 10.1002/rmb2.70040 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 12.03.2026. Verfasst von Daiki Hiratsuka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Graduate School of Medicine The University of Tokyo Tokyo Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recurrent implantation failure (RIF) is an infertility condition in which uterine factors remain difficult to diagnose and treat. Recent studies implicate the endometrial microbiome in implantation.

Methods

This clinically oriented narrative review summarizes female reproductive tract microbiota and evidence on endometrial microbiome testing and management in infertility. Main Findings (Results) Vaginal dysbiosis is linked to adverse reproductive outcomes and provides a reference for interpreting upper‐tract findings. Endometrial microbial signals are detectable by sequencing, but interpretation is challenged by the low‐biomass environment and vulnerability to carry‐over, kitome effects, and contamination. Across ART studies, a Lactobacillus ‐enriched endometrial profile is more often associated with favorable pregnancy‐related outcomes, whereas non– Lactobacillus ‐dominant patterns are more frequently reported in implantation failure, although effect sizes and statistical significance vary across cohorts and depend on sampling validity and cutoff definitions. Limited nonrandomized intervention studies suggest that testing‐guided targeted management (typically antibiotics with or without vaginal Lactobacillus ‐containing probiotics) may benefit selected patients, but protocols are heterogeneous and results remain inconsistent.

Conclusion

Evidence is rapidly evolving, yet observational designs and methodological variability limit causal inference. Future progress will require standardized sampling and contamination controls, outcome‐anchored threshold validation, and pragmatic real‐world evaluations of protocolized test‐and‐treat pathways using clinically meaningful endpoints.

Schlagwörter

Stichwörter der Autor:innen

Lactobacillusdysbiosisendometriumimplantationmicrobiota

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Graduate School of Medicine The University of Tokyo Tokyo Japan.

ORCID-Profile: Daiki Hiratsuka

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency

Zitieren

APA

Hiratsuka, D., Matsuo, M., & Hirota, Y. (2026). Endometrial Microbiome and Implantation: From Basic Knowledge to Clinical Medicine. Reproductive Medicine and Biology, 25(1). https://doi.org/10.1002/rmb2.70040

Vancouver

Hiratsuka D, Matsuo M, Hirota Y. Endometrial Microbiome and Implantation: From Basic Knowledge to Clinical Medicine. Reproductive Medicine and Biology. 2026;25(1). doi:10.1002/rmb2.70040

BibTeX
@article{Hiratsuka2026,
  author = {Hiratsuka, Daiki and Matsuo, Mitsunori and Hirota, Yasushi},
  title = {Endometrial Microbiome and Implantation: From Basic Knowledge to Clinical Medicine},
  journal = {Reproductive Medicine and Biology},
  year = {2026},
  volume = {25},
  number = {1},
  doi = {10.1002/rmb2.70040}
}
Kostenlos starten →